MTT Analysis Protocol
GUIDELINE
This experiment describes a method to detect cell survival and growth-MTT analysis assay. The principle of the assay is that the enzyme succinate dehydrogenase in the mitochondria of living cells reduces exogenous MTT to water-insoluble blue-violet crystals of Formazan and deposits them in the cells, whereas dead cells do not have this function. Dimethyl sulfoxide (DMSO) dissolves Formazan in the cells, and its light absorption value is measured at 490 nm with an enzyme marker, and the amount of MTT crystals formed is proportional to the number of cells within a certain cell number range. According to the measured absorbance value (OD value), to determine the number of living cells, the larger the OD value, the stronger the cell activity (if it is to measure the drug toxicity, it means that the drug toxicity is smaller).
METHODS
- Trypsin digestion of log phase cells is terminated and collected by centrifugation to make cell suspension. The concentration is adjusted to 5-10×104/ml for cell counting.
- The cell suspension is prepared and gently mixed. 100 μl per well is added so that the density of cells to be tested is 5000-10000/well (edge wells are filled with sterile PBS).
- Put the inoculated cell culture plate into the incubator and incubate it until the cell monolayer spreads over the bottom of the wells (96-well flat-bottomed plate), and add the drug with the concentration gradient. Generally, 5-7 gradients, 100 μl per well, set up 3-5 compound wells. It is recommended to set up 6, otherwise, it is difficult to reflect the real situation.
- 5% CO2, incubate at 37°C for 16-48 hours and observe the effect of the drug under the inverted microscope.
- Add 10 μl MTT solution (5 mg/ml, i.e. 0.5% MTT) to each well, and continue incubation for 4 h. If the drug and MTT can react, centrifuge and discard the culture solution first, and then add the MTT-containing culture solution after carefully rinsing it with PBS 2-3 times.
- Terminate the incubation and prepare to dissolve the crystals. MTT is added to incubate for 4 h, the crystals can be fully formed. 150 μl of dimethyl sulfoxide is added to each well and placed on a shaker with low-speed shaking for 10 min to fully dissolve the crystals. The absorbance value of each well is measured at OD490 nm of the enzyme immunoassay detector.
- Zeroing wells (culture medium, MTT, dimethyl sulfoxide) and control wells (cells, same concentration of drug dissolution medium, culture medium, MTT, dimethyl sulfoxide) are also set up.
Creative Bioarray Relevant Recommendations
- Creative Bioarray provides SuperQuick® cell proliferation kit I (MTT) which is a colorimetric assay for the non-radioactive quantification of cellular proliferation, viability, and cytotoxicity. The sample material is either adherent or suspension cells cultured in 96-well microplates.
- We also offer a wide selection of cell viability assays for drug screening and cytotoxicity tests of chemicals, including MTT/MST/WST-8/WST-1/CKK-8 assays, trypan blue assays, calcein-AM assays, fluorescent reactive dye assays, single/two color viability assays, and microplate cell viability assays.
NOTES
- Because the cells continue to settle even after mixing, the inoculation process should be repeated several times. For example, mixing every 6 wells is added to ensure that the density of inoculated cells is the same from one well to another, which is crucial for the results of MTT. In addition, the number of cells should also be determined according to the characteristics of the cells themselves, such as the growth rate.
- In principle, the drug can be added after the cells are attached to the wall, for two hours, or half a day. But we often lay the plate in the afternoon of the previous day and add the drug in the morning of the next day.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.
Resources
- FAQ
- Posters & Downloads
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Techniques for Cell Separation
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- Comparison of the MSCs from Different Sources
- T Cell Activation and Expansion
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Cell Cryopreservation Techniques and Practices
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- What Is Cell Proliferation and How to Analyze It?
- Direct vs. Indirect Cell-Based ELISA
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- STR Profiling—The ID Card of Cell Line
- How to Assess the Migratory and Invasive Capacity of Cells?
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- Quantification of Cytokines
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Cell Culture Medium
- IL-12 Family Cytokines and Their Immune Functions
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- How to Scale Up Single-Cell Clones?
- What are Mesothelial Cells?
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- What are the Differences Between M1 and M2 Macrophages?
- Mesenchymal Stem Cells: A Comprehensive Exploration
- Human Primary Cells: Definition, Assay, Applications
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Tips For Cell Cryopreservation
- How to Decide Between 2D and 3D Cell Cultures?
- CHO Cell Line Development
- How to Eliminate Mycoplasma From Cell Cultures?
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- How to Isolate PBMCs from Whole Blood?
- How to Handle Mycoplasma in Cell Culture?
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- ddPCR vs qPCR vs NGS: Which Platform Fits Your Research?
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Role of Cell-Based Assays in Drug Discovery and Development
- Immunogenicity Testing: ELISA and MSD Assays
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- Optimization Strategies of Cell-Based Assays
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Overview of Cell Apoptosis Assays
- Cell-Based High-Throughput Screening Techniques
- Cell Immortalization Step by Step
- Adherent and Suspension Cell Culture
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Cell Viability, Proliferation and Cytotoxicity Assays
- What Are CAR T Cells?
- Eosinophils vs. Basophils vs. Neutrophils
- Cultivated Meat: What to Know?
- 3D-Cell Model in Cell-Based Assay
- What Are the Pros and Cons of Adoptive Cell Therapy?
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Understanding Immunogenicity Assays: A Comprehensive Guide
-
Histology
- Fluorescent Nuclear Staining Dyes
- Stains Used in Histology
- Troubleshooting in Fluorescent Staining
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- Cell Lysates: Composition, Properties, and Preparation
- Multiple Animal Tissue Arrays
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Tips for Choosing the Right Protease Inhibitor
- Mitochondrial Staining
- Guides for Live Cell Imaging Dyes
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- How to Begin with Multiplex Immunohistochemistry (mIHC)
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- Modern Histological Techniques
- What You Must Know About Neuroscience IHC?
- How Immunohistochemistry Makes the Invisible Brain Visible?
- From Specimen to Slide: Core Methods in Histological Practice
- Multiplexing Immunohistochemistry
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- Serum vs. Plasma
-
Exosome
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- Classification, Isolation Techniques and Characterization of Exosomes
- Emerging Technologies and Methodologies for Exosome Research
- Common Techniques for Exosome Nucleic Acid Extraction
- How Important are Lipids in Exosome Composition and Biogenesis?
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- What are the Functions of Exosomal Proteins?
- Exosome Size Measurement
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Perform Targeted Modification of Exosomes?
- How to Apply Exosomes in Clinical?
- Techniques for Exosome Quantification
- How to characterize exosomes?
- Exosome Transfection for Altering Biomolecular Delivery
- Summary of Approaches for Loading Cargo into Exosomes
- Exosome Antibodies
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- The Role of Exosomes in Cancer
- How to Enhancement Exosome Production?
- What's the Potential of PELN in Disease Treatment?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- How to Label Exosomes?
- Unraveling Biogenesis and Composition of Exosomes
-
ISH/FISH
- ISH probe labeling method
- Multiple Approaches to Karyotyping
- In Situ Hybridization Probes
- CARD-FISH: Illuminating Microbial Diversity
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- RNAscope ISH Technology
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Overview of Common FISH Techniques
- Guidelines for the Design of FISH Probes
- Small RNA Detection by ISH Methods
- Differences Between DNA and RNA Probes
- Overview of Oligo-FISH Technology
- FISH Tips and Troubleshooting
- How to Use FISH in Hematologic Neoplasms?
- What are the Differences between FISH, aCGH, and NGS?
- Comparative Genomic Hybridization and Its Applications
- Telomere Length Measurement Methods
- Different Types of FISH Probes for Oncology Research
- What Types of Multicolor FISH Probe Sets Are Available?
- What Is the Use of FISH in Solid Tumors?
- Reagents Used in FISH Experiments
- What are Single, Dual, and Multiplex ISH?
- Mapping of Transgenes by FISH
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- Toxicokinetics vs. Pharmacokinetics
- What Are Metabolism-Mediated Drug-Drug Interactions?
- How to Improve Drug Plasma Stability?
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Traditional vs. Novel Drug Delivery Methods
- Key Factors Influencing Brain Distribution of Drugs
- The Rise of In Vitro Testing in Drug Development
- Overview of In Vitro Permeability Assays
- Predictive Modeling of Metabolic Drug Toxicity
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Key Considerations in Toxicokinetic
- Organ-on-a-Chip Systems for Drug Screening
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- Physical and Chemical Properties of Drugs and Calculations
- Experimental Methods for Identifying Drug-Drug Interactions
- How to Conduct a Bioavailability Assessment?
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Unraveling the Role of hERG Channels in Drug Safety
- Methods of Parallel Artificial Membrane Permeability Assays
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- What Are Compartment Models in Pharmacokinetics?
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- Pharmacokinetics of Therapeutic Peptides
- Comparing Plasma Protein Binding Methods
- Why iPSC-derived Cells are Useful in Toxicology?
- The Essentials of Quantitative Bioanalysis
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- How Are Biomarkers Validated in Drug Development?
- Biomarkers vs. Functional Assays: Closing the Preclinical Gap
- When Should You Introduce ADME Tox Testing in Drug Development?
- How Can You Optimize Drug Toxicity Assessment?
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- What Are Biomarkers in Drug Discovery?
- The Bioanalysis Masterclass: Labile Metabolites
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- 2D vs 3D Cell Culture Models: Which Is Best for Drug Toxicity Testing?
- Bioanalysis Errors: How to Spot and Fix Them Early
- Troubleshooting Common Issues in Drug Toxicity Testing
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- Preclinical Workflow for Drug Toxicity Testing
- In Vitro ADME vs In Vivo ADME
- A Complete Guide to CYP Reaction Phenotyping in 2026
- Mastering the Noise: A Practical Guide to Minimizing Variability in Preclinical Studies
- How to Interpret CYP Phenotyping Data
- Reaction Phenotyping vs. Metabolic Stability
- The 8 Types of Drug Toxicity Every Researcher Must Know
- Why Cardiotoxicity Matters in R&D?
- What Are the Best Methods to Test Cardiotoxicity?
-
Disease Models
- Animal Models of Neurodegenerative Diseases
- Disease Models of Diabetes Mellitus
- Summary of Advantages and Limitations of Different Oncology Animal Models
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Why Use PDX Models for Cancer Research?
- Preclinical Models of Acute Liver Failure
- Implementing NAMs in Drug Development
- Why Oncology Organoids Fail? How to Build Models That Work
- Organ-on-a-Chip: Is Your Microfluidic Setup Ready for Preclinical Trials?
- Oncology Model Strategy: From Screening to Validation
- How to Select the Right Preclinical Model for Drug Development
- How to Match Models to Drug Modalities: Small Molecules vs. Biologics
- How to Select the Right Humanized Mouse Model for Immuno-Oncology
- Animal Models vs. NAMs: Understanding Modern Preclinical Research
- Organoids vs Organ-on-Chip: Which is More Predictive?
- Humanized Mouse Models: Core Technical Considerations
- Static vs. Dynamic In Vitro Models
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter

